Coagulation Factor IX variant
DLZ-201
Phase 2 mab completed
Quick answer
Coagulation Factor IX variant for Hemophilia B is a Phase 2 program (mab) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Hemophilia B
- Phase
- Phase 2
- Modality
- mab
- Status
- completed